Exploring cancer metabolism
Matthew Vander Heiden seeks new cancer treatments that exploit tumor cells’ abnormal metabolism.
Matthew Vander Heiden seeks new cancer treatments that exploit tumor cells’ abnormal metabolism.
Biologists discover that the environment surrounding a cell plays an integral role in its ability to accurately segregate its chromosomes.
Findings suggest mechanisms for the persistence of nasal polyps and possible new treatment strategies.
The new Convergence Scholars Program bridges disciplines and helps young researchers further their skills and build their brands as scientists.
Unexpected findings show that the body’s own immune system destroys retinal cells.
With new method, surgeons would remove tumor, then implant microparticles that attack remaining cancer cells.
Faculty members recognized for excellence via a diverse array of honors, grants, and prizes over the last quarter.
Polymeric nanoparticles can efficiently administer mRNA to cells of the lungs, liver, and other organs.
Drugs carried in cellular “backpacks” help T cells to destroy tumors.
MIT researchers develop new tools to enable targeted delivery of drugs to deep brain structures through implanted microprobes.
Researchers identify the amino acid aspartate as a metabolic limitation in certain cancers.
Shortfall of digestive enzymes can lead to tissue breakdown in early stages of pancreatic cancer.
Researchers generate an intestinal cell mimic that can be harnessed in studies of diseases such as inflammatory bowel disease.
Institute Professor chosen to help forge connections and identify opportunities for sustained international cooperation.
Scientists leverage one step, unbiased method to characterize the binding preferences of more than 70 human RNA-binding proteins.